Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

InspireMD (NSPR) Return on Sales (2016 - 2025)

InspireMD (NSPR) has 16 years of Return on Sales data on record, last reported at 5.17% in Q3 2025.

  • For Q3 2025, Return on Sales fell 50.0% year-over-year to 5.17%; the TTM value through Sep 2025 reached 6.03%, down 164.0%, while the annual FY2024 figure was 4.57%, 136.0% down from the prior year.
  • Return on Sales reached 5.17% in Q3 2025 per NSPR's latest filing, up from 7.32% in the prior quarter.
  • Across five years, Return on Sales topped out at 2.94% in Q4 2021 and bottomed at 7.5% in Q1 2025.
  • Average Return on Sales over 5 years is 4.25%, with a median of 3.79% recorded in 2022.
  • Peak YoY movement for Return on Sales: surged 2060bps in 2021, then tumbled -259bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 2.94% in 2021, then crashed by -60bps to 4.69% in 2022, then grew by 30bps to 3.3% in 2023, then crashed by -46bps to 4.81% in 2024, then decreased by -8bps to 5.17% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 5.17% in Q3 2025, 7.32% in Q2 2025, and 7.5% in Q1 2025.